gms | German Medical Science

57. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie e. V. (DGNC)
Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

11. bis 14.05.2006, Essen

Endothelial ephrinB2/EphB4 signaling controls permeability of glioma blood vessels

EphrinB2/EphB4 abhängige Signaltransduktion im Endothel bestimmt die Permeabilität von Blutgefässen im Gliom

Meeting Abstract

  • corresponding author R. Erber - Department of Neurosurgery, Mannheim
  • U. Eichelsbacher - Max-Planck-Institute for Biochemistry, Martinsried
  • V. Powajbo - Department of Neurosurgery, Mannheim
  • T. Korn - Department of Neurosurgery, Mannheim
  • V. Djonov - Institute of Anatomy, Bern/CH
  • A. Ullrich - Max-Planck-Institute for Biochemistry, Martinsried
  • P. Vajkoczy - Department of Neurosurgery, Mannheim

Deutsche Gesellschaft für Neurochirurgie. Japanische Gesellschaft für Neurochirurgie. 57. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie e.V. (DGNC), Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie. Essen, 11.-14.05.2006. Düsseldorf, Köln: German Medical Science; 2006. DocP 05.63

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter: http://www.egms.de/de/meetings/dgnc2006/06dgnc280.shtml

Veröffentlicht: 8. Mai 2006

© 2006 Erber et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Objective: The receptor tyrosine kinase EphB4 and its ligand ephrinB2 have been suggested to be critical for vascular development. Recently, we have demonstrated that both molecules are expressed within glioma blood vessels. The objective of this study was to address the role of ephrinB2/EphB4 signaling in the regulation of glioma blood vessel permeability.

Methods: To study their role in the regulation of tumor blood vessel permeability, the EphB4 wild type receptor (EphB4wt) and a signaling defective dominant-negative mutant form of EphB4 (EphB4dn) were overexpressed specifically in blood vessels of glioma xenografts using a retroviral approach. Expression of the empty control vector served as control (pLXSN).

Results: Intravital fluorescence microscopy revealed a 20-30% decrease in tumor blood vessel permeability in EphB4wt and EphB4dn transfected vessels. As a potential mechanism RT-PCR demonstrated an increased expression of the vessel stabilizing factor Ang-1 in both groups. In parallel its endothelial receptor Tie2 was characterized by increased phopshorylation and activation levels. In situ hybridization identified pericytes as the source of Ang-1. To gain more insight into the cellular consequences of Ang-1/Tie2 activation, electron microscopic studies of glioma blood vessels were performed. These studies demonstrated a sealing and stabilization of glioma blood vessel via a tight assembly of pericytes to the endothelium.

Conclusions: EphB4 signaling reduces the permeability of glioma blood vessels through a link to the Ang-1/Tie2 system, independently of the EphB4 kinase domain. Intervention with this molecule may provide novel opportunities for the development of anti-glioma strategies.